Literature DB >> 1482636

Plasma atrial natriuretic peptide and endothelin levels in acute poststreptococcal glomerulonephritis.

S Ozdemir1, U Saatçi, N Beşbaş, A Bakkaloglu, S Ozen, Z Koray.   

Abstract

Plasma levels of atrial natriuretic peptide (ANP) and of endothelin (ET) were significantly elevated (87.7 +/- 13.9 pg/ml and 79.7 +/- 10.8pg/ml, respectively) during the acute phase of acute poststreptococcal glomerulonephritis (APSGN). Plasma renin levels were normal, fractional excretion of sodium (FENa) was 0.5 +/- 0.1% and creatinine clearance (CCr) averaged 82.2 +/- 18.3 ml/min per 1.73 m2. In the recovery phase of the disease (n = 12), levels of ANP (23.6 +/- 6.7 pg/ml) and ET (43.1 +/- 2.4 pg/ml) fell and were not significantly different from those measured in 11 control subjects. FENa increased to 1.3 +/- 0.1% and CCr to 113.5 +/- 12.1 ml/min per 1.73 m2 (all values mean +/- standard error). ANP did not correlate with PRA, blood pressure, CCr or FENa. There was an inverse relationship between the ET level and FENa in the acute phase of the disease (r = 0.489, P < 0.05), but no significant correlation between ET and blood pressure, PRA, CCr or ANP was found. We suggest that, despite the sodium retention, the increased ANP level in APSGN indicates unresponsiveness of the kidneys to ANP; the increased ET levels may contribute to this.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482636     DOI: 10.1007/bf00866489

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Integrated cardiac, renal, and endocrine actions of endothelin.

Authors:  W L Miller; M M Redfield; J C Burnett
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Endothelin-1-induced contractions of vascular and tracheal smooth muscle: effects of nicardipine and BRL 34915.

Authors:  N C Turner; C T Dollery; A J Williams
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

3.  Endothelin in renal failure.

Authors:  A N Warrens; M J Cassidy; K Takahashi; M A Ghatei; S R Bloom
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

4.  Plasma endothelin levels in hypertension and chronic renal failure.

Authors:  M Shichiri; Y Hirata; K Ando; T Emori; K Ohta; S Kimoto; M Ogura; A Inoue; F Marumo
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

5.  Plasma level of atrial natriuretic peptide as an indicator of increased cardiac load in uremic patients.

Authors:  I Tikkanen; K Metsärinne; C Grönhagen-Riska; F Fyhrquist
Journal:  Clin Nephrol       Date:  1990-10       Impact factor: 0.975

Review 6.  Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis. A correlation between renal functions, morphologic damage and clinical course of 46 children with acute poststreptococcal glomerulonephritis.

Authors:  J E Lewy; L Salinas-Madrigal; P B Herdson; C L Pirani; J Metcoff
Journal:  Medicine (Baltimore)       Date:  1971-11       Impact factor: 1.889

7.  Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans.

Authors:  N E Bruun; P Skøtt; J Giese
Journal:  Am J Physiol       Date:  1991-01

8.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

9.  Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes.

Authors:  Y Fukuda; Y Hirata; H Yoshimi; T Kojima; Y Kobayashi; M Yanagisawa; T Masaki
Journal:  Biochem Biophys Res Commun       Date:  1988-08-30       Impact factor: 3.575

10.  Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis.

Authors:  S S Sørensen; H Danielsen; E B Pedersen
Journal:  Scand J Clin Lab Invest       Date:  1988-06       Impact factor: 1.713

View more
  1 in total

1.  Modulation by endogenous prostanoids of the vasoconstrictor activity of endothelin-1 in the canine isolated, perfused spleen.

Authors:  D M Grassi-Kassisse; E Antunes; P G Withrington; G de Nucci
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.